Some Thiocyanate Containing Heterocyclic Compounds: Synthesis, Bioactivity and Molecular Docking Study

dc.contributor.authorIsrafilova, Zubeyda
dc.contributor.authorTaslimi, Parham
dc.contributor.authorGülçin, İlhami
dc.contributor.authorAbdullayev, Yusif
dc.contributor.authorFarzaliyev, Vagif
dc.contributor.authorKaraman, Muhammet
dc.contributor.authorSujayev, Afsun
dc.contributor.authorTaslimi, Parham
dc.date.accessioned2025-10-18T09:58:45Z
dc.date.created2023
dc.date.issued2023
dc.departmentFakülteler, Fen Fakültesi, Biyoteknoloji Bölümü
dc.description.abstractThis study focuses on the synthesis of some thiocyanate containing heterocyclic compounds. Theoretical calculations are conducted to genergate a mechanism for substituting chloride with thiocyanate in 2-(chloromethyl)aziridine derivatives, which result in formation of thiocyanate-based aziridine derivatives. Computations reveal that the two similar reactions have a different reaction profile, namely E1 formation is endergonic (+32.8 kcal/mol) while the E2 formation is exergonic (-62.8 kcal/mol). All heterocyclic molecules were determined for human carbonic anhydrase I, II (hCAs I and II), acetylcholinesterase (AChE), and alpha-glycosidase inhibitory abilities. Results indicated that all the synthetic compounds exhibited potent inhibitory abilities against all targets as compared to the standard inhibitors, revealed by IC50 values. K-i values of novel group E1-E3 for hCA I, hCA II, AChE, and alpha-glycosidase enzymes were obtained in the ranges 4.08-15.04, 12.51-24.37, 52.07-81.21 and 1076.38-1287.55 mu M, respectively. Molecular modeling results have shown that the most active molecules have binding affinity with -6.204, -4.423, -6.298, and -6.623 kcal/mol against hCA II, hCA I, alpha-glycosidase, and AChE enzymes, respectively. Thiocyanate moiety specifically inhibited hCA I and hCA II enzymes. CA inhibitors have the ability to dilate retinal capillaries and suppress capillary blockage.
dc.description.sponsorshipKing Saud University's Researchers Supporting Project [RSP-2022/59]; Science Development Fund under the President of Azerbaijan Republic [NoEIF-ETL-2020-2(36)-16/11/4-m-11]
dc.description.sponsorshipSaleh Alwasel wishes to express his heartfelt gratitude to King Saud University's Researchers Supporting Project (RSP-2022/59). Also, this work was carried out with the support of the Science Development Fund under the President of Azerbaijan Republic- Grant NoEIF-ETL-2020-2(36)-16/11/4-m-11.
dc.identifier.doi10.1002/slct.202203653
dc.identifier.issn2365-6549
dc.identifier.issue3
dc.identifier.orcidSucayev, Afsun/0000-0002-4135-9568
dc.identifier.orcidFarzaliyev, Vagif/0009-0004-4301-475X
dc.identifier.orcidTaslimi, Parham/0000-0002-3171-0633
dc.identifier.orcidKaraman, Muhammet/0000-0002-0155-3390;
dc.identifier.scopus2-s2.0-85147044009
dc.identifier.scopusqualityQ3
dc.identifier.urihttps://doi.org/10.1002/slct.202203653
dc.identifier.urihttps://hdl.handle.net/11772/19818
dc.identifier.volume8
dc.identifier.wosWOS:000920130500001
dc.identifier.wosqualityQ3
dc.indekslendigikaynakWeb of Science
dc.indekslendigikaynakScopus
dc.language.isoen
dc.publisherWiley-V C H Verlag Gmbh
dc.relation.ispartofChemistryselect
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanı
dc.rightsinfo:eu-repo/semantics/closedAccess
dc.snmzWoS_20251016
dc.subjectAziridine
dc.subjectEnzyme Inhibition
dc.subjectMolecular Docking
dc.subjectPolyfunctional
dc.subjectSynthesis
dc.titleSome Thiocyanate Containing Heterocyclic Compounds: Synthesis, Bioactivity and Molecular Docking Study
dc.typeArticle
dspace.entity.typePublication
relation.isAuthorOfPublicationdadfa319-65b8-4543-92b4-bea49e0139e9
relation.isAuthorOfPublication.latestForDiscoverydadfa319-65b8-4543-92b4-bea49e0139e9

Dosyalar